D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
PayPal
PYPL
|
+$333M |
| 2 |
Microsoft
MSFT
|
+$311M |
| 3 |
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
|
+$310M |
| 4 |
Automatic Data Processing
ADP
|
+$260M |
| 5 |
Citigroup
C
|
+$255M |
Top Sells
| 1 |
APC
Anadarko Petroleum
APC
|
+$567M |
| 2 |
Fidelity National Information Services
FIS
|
+$410M |
| 3 |
Medtronic
MDT
|
+$374M |
| 4 |
ATVI
Activision Blizzard Inc.
ATVI
|
+$288M |
| 5 |
Amazon
AMZN
|
+$278M |
Sector Composition
| 1 | Technology | 19.13% |
| 2 | Consumer Discretionary | 16.65% |
| 3 | Healthcare | 15.2% |
| 4 | Financials | 10.49% |
| 5 | Industrials | 8.32% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBPX
501
DELISTED
CONTINENTAL BUILDING PRODUCTS, INC.
CBPX
| $24.2M | 0.03% |
886,769
-185,274
| -17% | -$5.06M |
|
502
Zimmer Biomet
ZBH
$20.4B
| $24.2M | 0.03% |
181,505
-680,594
| -79% | -$90.7M |
|
503
Laureate Education
LAUR
$4.07B
| $24.2M | 0.03% |
1,459,301
+733,772
| +101% | +$12.2M |
|
504
DNOW Inc
DNOW
$1.61B
| $24M | 0.03% |
2,092,213
-124,918
| -6% | -$1.43M |
|
505
Adtalem Global Education
ATGE
$4.83B
| $24M | 0.03% |
629,597
+124,889
| +25% | +$4.76M |
|
506
Vornado Realty Trust
VNO
$7.71B
| $23.8M | 0.03% |
373,785
+317,025
| +559% | +$20.2M |
|
507
Yext
YEXT
$1.04B
| $23.8M | 0.03% |
1,497,137
-454,815
| -23% | -$7.23M |
|
508
Vanguard FTSE Emerging Markets ETF
VWO
$99B
| $23.7M | 0.03% |
589,444
| – | – |
|
|
MNTA
509
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
| $23.7M | 0.03% |
1,826,331
-88,363
| -5% | -$1.15M |
|
|
MGLN
510
DELISTED
Magellan Health Services, Inc.
MGLN
| $23.6M | 0.03% |
379,892
+114,543
| +43% | +$7.11M |
|
511
Usana Health Sciences
USNA
$552M
| $23.4M | 0.03% |
342,590
+71,147
| +26% | +$4.87M |
|
512
Perdoceo Education
PRDO
$2.16B
| $23.3M | 0.03% |
1,467,420
+263,937
| +22% | +$4.19M |
|
513
Avnet
AVT
$4.49B
| $23M | 0.03% |
516,336
+150,180
| +41% | +$6.68M |
|
514
Linde
LIN
$221B
| $22.9M | 0.03% |
118,210
+94,813
| +405% | +$18.4M |
|
515
Huntsman Corp
HUN
$1.87B
| $22.9M | 0.03% |
983,999
-372,203
| -27% | -$8.66M |
|
|
ACC
516
DELISTED
American Campus Communities, Inc.
ACC
| $22.8M | 0.03% |
473,943
+105,626
| +29% | +$5.08M |
|
|
CCI.PRA
517
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
| $22.8M | 0.03% |
+18,000
| New | +$22.8M |
|
518
Masco
MAS
$15.4B
| $22.7M | 0.03% |
545,678
-414,669
| -43% | -$17.3M |
|
519
OraSure Technologies
OSUR
$239M
| $22.7M | 0.03% |
3,044,118
+72,252
| +2% | +$540K |
|
|
SRCI
520
DELISTED
SRC Energy Inc
SRCI
| $22.7M | 0.03% |
4,869,394
+384,852
| +9% | +$1.79M |
|
|
HIBB
521
DELISTED
Hibbett, Inc. Common Stock
HIBB
| $22.6M | 0.03% |
986,204
-104,936
| -10% | -$2.4M |
|
522
Hexcel
HXL
$4.9B
| $22.4M | 0.03% |
273,073
-63,687
| -19% | -$5.23M |
|
523
Anika Therapeutics
ANIK
$123M
| $22.4M | 0.03% |
408,294
-4,757
| -1% | -$261K |
|
524
Amicus Therapeutics
FOLD
$2.44B
| $22.4M | 0.03% |
2,791,844
+644,441
| +30% | +$5.17M |
|
525
Editas Medicine
EDIT
$236M
| $22.2M | 0.03% |
977,604
+354,273
| +57% | +$8.06M |
|